N90.5 Atrophy of vulva

Name of the Condition

• Atrophy of vulva

Summary

Atrophy of the vulva refers to the thinning, drying, and inflammation of the vulvar tissues, often due to reduced estrogen levels. This condition can lead to discomfort, increased susceptibility to irritation, and changes in the vulvar appearance. It is commonly associated with menopause but may also occur in other hormonal or age-related contexts.

Causes

The primary cause of vulvar atrophy is decreased estrogen production, which typically occurs during menopause. Other potential causes include radiation therapy, surgical removal of the ovaries, or certain medical conditions affecting hormone levels. In some cases, the underlying cause may remain unspecified.

Risk Factors

• Advanced age, particularly postmenopausal status.
• Surgical procedures that reduce estrogen levels, such as oophorectomy.
• Radiation therapy to the pelvic region.
• Chronic conditions affecting hormone balance, like hypogonadism.
• Prolonged use of medications that lower estrogen.

Symptoms

• Dryness, itching, or burning in the vulvar area.
• Thinning or pale appearance of the vulvar skin.
• Pain or discomfort during intercourse.
• Increased susceptibility to irritation or infection.
• Urinary symptoms, such as urgency or frequency.

Diagnosis

Diagnosis is typically based on a physical examination of the vulva, assessing for thinning, redness, or other signs of atrophy. Healthcare providers may also review the patient’s medical history, including hormonal changes or related treatments. In some cases, additional tests may be performed to rule out other conditions.

Treatment Options

• Topical estrogen therapy: Creams, rings, or tablets to restore vulvar tissue health.
• Moisturizers or lubricants: To alleviate dryness and discomfort.
• Lifestyle adjustments: Avoiding irritants, such as harsh soaps or tight clothing.
• Systemic hormone therapy: For patients with broader hormonal imbalances.

Prognosis and Follow-Up

With appropriate treatment, symptoms often improve over time. Regular follow-up may be recommended to monitor tissue health and adjust therapy as needed. Untreated atrophy may persist or worsen, potentially leading to chronic discomfort or increased infection risk.

Complications

• Increased risk of vulvar infections due to thinning skin.
• Persistent pain or discomfort affecting quality of life.
• Emotional or psychological distress related to symptoms.

Lifestyle & Prevention

• Using gentle, fragrance-free products for vulvar care.
• Staying hydrated and maintaining overall skin health.
• Engaging in regular, gentle physical activity to support circulation.
• Discussing hormonal health with a healthcare provider, especially during menopause.

When to Seek Professional Help

Seek care if symptoms such as severe pain, persistent itching, or unusual discharge occur. Early evaluation is recommended if atrophy is suspected, particularly in postmenopausal individuals or those with risk factors.

Tips for Medical Coders

When coding for atrophy of the vulva (N90.5), ensure documentation supports the diagnosis, including clinical findings and any relevant patient history. Note that this code is specific to vulvar atrophy and should not be used for generalized skin atrophy or other anatomical sites. Verify that the code aligns with the clinical presentation and any associated treatments or evaluations.